SECURIAN ASSET MANAGEMENT, INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 272 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
SECURIAN ASSET MANAGEMENT, INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$243,953
-28.2%
9,079
-4.7%
0.01%
-22.2%
Q2 2023$339,590
+35.5%
9,523
-3.5%
0.01%
+28.6%
Q1 2023$250,546
-35.9%
9,864
+2.3%
0.01%
-36.4%
Q4 2022$390,958
+22.6%
9,6390.0%0.01%
+10.0%
Q3 2022$319,000
-5.9%
9,6390.0%0.01%
+25.0%
Q2 2022$339,000
-22.1%
9,639
+1.9%
0.01%0.0%
Q1 2022$435,000
-29.8%
9,462
+1.2%
0.01%
-27.3%
Q4 2021$620,000
+6.2%
9,3500.0%0.01%
-8.3%
Q3 2021$584,000
-26.3%
9,350
-2.2%
0.01%
-25.0%
Q2 2021$792,000
+22.6%
9,565
-1.8%
0.02%
+14.3%
Q1 2021$646,000
-13.5%
9,7400.0%0.01%
-17.6%
Q4 2020$747,000
+74.5%
9,740
-2.0%
0.02%
+70.0%
Q3 2020$428,000
-3.6%
9,934
-3.3%
0.01%
-9.1%
Q2 2020$444,000
+50.0%
10,2770.0%0.01%
+37.5%
Q1 2020$296,000
-54.6%
10,2770.0%0.01%
-42.9%
Q4 2019$652,00010,2770.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders